Specifically, 0.4 mL of CSF, collected from AD patient, was incubated with 100 ng of one of the two TCO‐grafted antibodies targeting NEV markers, i.e., TCO‐anti‐L1CAM or TCO‐anti‐NCAM. Here, L1CAM is linked to Alzheimer disease.